Regular follow-up appointments allow us to track your progress, adjust your dosing as needed, and provide tailored support to help you achieve your health and weight loss goals safely and effectively
Song et al., 2016)
Short-acting formulations like exenatide (Byetta) clear within 1224 hours, while long-acting options such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can take 45 weeks to fully eliminate
GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions
Use manufacturer savings programs Programs like NovoCare (for Wegovy) and LillyDirect (for Zepbound) may offer discounted cash-pay pricing for eligible patients
Slow and gradual dose adjustments are key for this group, as they help reduce the risk of gastrointestinal side effects like nausea and vomiting, which could lead to volume depletion
